How many stocks are there of Sensorion?
The current number of stocks of Sensorion is 133.42 M undefined.
Sensorion Stocks 2024
Sensorion Stocks
133.42 M
Ticker
ALSEN.PA
ISIN
FR0012596468
WKN
A14SVV
In 2024, Sensorion had 133.42 M outstanding stocks, a 0% change from the 133.42 M stocks in the previous year.
The Sensorion Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 133.42 |
| 2028e | 133.42 |
| 2027e | 133.42 |
| 2026e | 133.42 |
| 2025e | 133.42 |
| 2024e | 133.42 |
| 2023 | 133.42 |
| 2022 | 79.84 |
| 2021 | 79.69 |
| 2020 | 60.76 |
| 2019 | 18.65 |
| 2018 | 11.41 |
| 2017 | 7.21 |
| 2016 | 6.42 |
| 2015 | 4.05 |
| 2014 | 3.26 |
| 2013 | 3.26 |
| 2012 | 3.26 |
Sensorion shares outstanding FR0012596468 · A14SVV
The number of shares was Sensorion in 2023 — This indicates how many shares 133.423 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Sensorion earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Sensorion's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Sensorion’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sensorion's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2012 | 3.26 M Aktien |
| 2013 | 3.26 M Aktien |
| 2014 | 3.26 M Aktien |
| 2015 | 4.05 M Aktien |
| 2016 | 6.42 M Aktien |
| 2017 | 7.21 M Aktien |
| 2018 | 11.41 M Aktien |
| 2019 | 18.65 M Aktien |
| 2020 | 60.76 M Aktien |
| 2021 | 79.69 M Aktien |
| 2022 | 79.84 M Aktien |
| 2023 | 133.42 M Aktien |
| 2024e | 133.42 M Aktien |
| 2025e | 133.42 M Aktien |
| 2026e | 133.42 M Aktien |
| 2027e | 133.42 M Aktien |
| 2028e | 133.42 M Aktien |
| 2029e | 133.42 M Aktien |
Sensorion Aktienanalyse
What does Sensorion do?
The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Sensorion's Shares Outstanding
Sensorion's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Sensorion’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Sensorion’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Sensorion’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Sensorion stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Sensorion are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Sensorion evolved in recent years?
The number of shares of Sensorion has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Sensorion as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Sensorion?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Sensorion pay?
Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Sensorion?
The current dividend yield of Sensorion is .
When does Sensorion pay dividends?
Sensorion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sensorion?
Sensorion paid dividends every year for the past 0 years.
What is the dividend of Sensorion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sensorion located?
Sensorion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sensorion from 10/3/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.
When did Sensorion pay the last dividend?
The last dividend was paid out on 10/3/2024.
What was the dividend of Sensorion in the year 2023?
In the year 2023, Sensorion distributed 0 EUR as dividends.
In which currency does Sensorion pay out the dividend?
The dividends of Sensorion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sensorion
Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
